Saniona AB (publ) (STO:SANION)
25.55
+0.95 (3.86%)
Feb 10, 2026, 5:29 PM CET
Saniona AB Revenue
Saniona AB had revenue of 410.74M SEK in the quarter ending September 30, 2025, with 5,577.15% growth. This brings the company's revenue in the last twelve months to 743.21M, up 2,687.51% year-over-year. In the year 2024, Saniona AB had annual revenue of 334.67M with 1,887.36% growth.
Revenue (ttm)
743.21M
Revenue Growth
+2,687.51%
P/S Ratio
4.57
Revenue / Employee
23.97M
Employees
31
Market Cap
3.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 334.67M | 317.83M | 1,887.36% |
| Dec 31, 2023 | 16.84M | 1.56M | 10.19% |
| Dec 31, 2022 | 15.28M | 4.81M | 45.86% |
| Dec 31, 2021 | 10.48M | 2.28M | 27.81% |
| Dec 31, 2020 | 8.20M | 997.00K | 13.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioInvent International AB | 244.85M |
| Hansa Biopharma AB | 178.61M |
| Genovis AB (publ.) | 117.66M |
| Oncopeptides AB | 62.47M |
| Egetis Therapeutics AB | 55.40M |
| Vicore Pharma Holding AB | 8.50M |
| Xspray Pharma AB | 3.81M |
| Flerie AB | 2.80M |
Saniona AB News
- 2 months ago - Saniona AB (FRA:30S) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial ... - GuruFocus
- 2 months ago - Q3 2025 Saniona AB Earnings Call Transcript - GuruFocus